Bluejay Diagnostics, Inc. Increase (Decrease) in Other Noncurrent Liabilities
Bluejay Diagnostics, Inc. (BJDX) reported Increase (Decrease) in Other Noncurrent Liabilities of -$59.79 thousand for the 9-month period ending 2024-09-30, per its 10-Q filed 2024-11-07.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities · last filed 2024-11-07
- Bluejay Diagnostics, Inc. increase (decrease) in other noncurrent liabilities for the quarter ending 2024-09-30 was -$18.16K.
| Period end | Increase (Decrease) in Other Noncurrent Liabilities 3 month | Increase (Decrease) in Other Noncurrent Liabilities 6 month | Increase (Decrease) in Other Noncurrent Liabilities 9 month |
|---|---|---|---|
| 2024-09-30 | -$18.16K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | -$59.79K 10-Q · filed 2024-11-07 | |
| 2024-06-30 | -$41.63K 10-Q · filed 2024-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |